Effective January 1, 2026, Rosemont Pharmaceuticals has announced the appointment of Alok Sonig as its new Chief Executive Officer, marking a significant leadership transition for the organization.
Alok Soni brings close to 30 years of experience in the global pharmaceutical industry, with leadership roles spanning strategy, research and development, biosimilars, and commercial operations across multiple geographies.
Prior to joining Rosemont Pharmaceuticals, he was with Baxter International Inc., where he most recently served as Executive Vice President and Group President, Pharmaceuticals, overseeing the company’s pharmaceutical business globally.
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
